Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine? Niegisch G. Br J Cancer 2020;122:453-454.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Niegisch G. Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine? Br J Cancer 2020;122:453-454.
PMID: 31857721